MISSION STATEMENT: Our mission is to provide unique solutions for oral drug delivery where conventional approaches have proven inadequate.

Our technologies provide opportunities for pharmaceutical product life cycle management and for enabling the commercial development of biotechnology products and other compounds that cannot be delivered orally.

TYPE OF COMPANY: Drug delivery; specialty pharmaceuticals

ADDRESS: 219 Racine Drive, Suite D, Wilmington, NC 28403-8702

PHONE NUMBER: (910) 799-1847

WEB SITE: www.merrionpharma.com

MANAGEMENT TEAM MEMBERS (include a brief background about each executive, with their title):

Michael J. McKenna, PhD, CEO, Merrion Pharmaceuticals, Inc., has 25 years of industry experience in new product development and safety evaluation as a toxicologist, R&D manager, senior pharmaceutical executive, and as an advisor to emerging biotechnology and pharmaceutical companies. Formerly with Dow Chemical, Parke-Davis, A.M. Pappas & Associates.

In addition to Dr. McKenna, other members of Merrion’s management team include:

Thomas W. Leonard, PhD, is VP and Chief Scientific Officer, with 20 years experience. He was formerly with Wyeth-Ayerst, aaiPharma, and Endeavor Pharmaceuticals. Dr. Leonard is the author of numerous publications and abstracts, as well as 14 issued patents and 11 patents in process.

John Lynch is the Managing Direction of Merrion Biopharma Ltd in Dublin, Ireland. He has 15 years of experience in both commercial and business development in international healthcare. He was formerly with Ernst & Young, Bayer Diagnostics and Abbott.

Aidan McGettigan, CFO, has 10 years experience in international finance and venture capital. He was formerly with Eagle Star, Morgan Stanley, Greenwich Natwest, and Growcorp.

BOARD MEMBERS: Michael McKenna; Michael Donnelly, Chairman, Growcorp Group; Fintan Maher, CEO Growcorp; Anthony Carragher, CFO, Irelandia Investments; Pat Wall, Partner, PriceWaterhouseCoopers, Dublin

INVESTORS::

Growcorp

European Bioscience Fund

Enterprise Ireland

Elan Pharmaceuticals plc

REVENUES: None

YEAR ESTABLISHED: 2004

NUMBER OF EMPLOYEES: 12